ASQGX
Price
$15.63
Change
-$0.31 (-1.94%)
Updated
Jun 13 closing price
Net Assets
143.86M
VSCIX
Price
$110.03
Change
-$1.80 (-1.61%)
Updated
Jun 13 closing price
Net Assets
147.56B
Interact to see
Advertisement

ASQGX vs VSCIX

Header iconASQGX vs VSCIX Comparison
Open Charts ASQGX vs VSCIXBanner chart's image
American Century Small Company R5
Price$15.63
Change-$0.31 (-1.94%)
VolumeN/A
Net Assets143.86M
Vanguard Small Cap Index I
Price$110.03
Change-$1.80 (-1.61%)
VolumeN/A
Net Assets147.56B
ASQGX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASQGX vs. VSCIX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASQGX is a Buy and VSCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 148B vs. ASQGX (144M). VSCIX pays higher dividends than ASQGX: VSCIX (1.49) vs ASQGX (0.52). ASQGX was incepted earlier than VSCIX: ASQGX (8 years) vs VSCIX (28 years). ASQGX (0.66) is less costly to investors than VSCIX (0.04). ASQGX is a more actively managed with annual turnover of: 67.00 vs. VSCIX (13.00). ASQGX has a lower initial minimum investment than VSCIX: ASQGX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 5.22 vs. ASQGX (1.27). VSCIX return over 5 years is better than : 63.40 vs. ASQGX (38.06).
ASQGXVSCIXASQGX / VSCIX
Total Expense Ratio0.660.041,650%
Annual Report Gross Expense Ratio0.660.041,650%
Fund Existence8 years28 years-
Gain YTD-3.792-4.35587%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets144M148B0%
Annual Yield % from dividends0.521.4935%
Returns for 1 year1.275.2224%
Returns for 3 years23.8231.3876%
Returns for 5 years38.0663.4060%
Returns for 10 yearsN/A93.42-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCRX10.37-0.03
-0.29%
BioCryst Pharmaceuticals
PAHC23.93-0.58
-2.37%
Phibro Animal Health Corp
DAY57.08-2.51
-4.21%
Dayforce
MMLP3.20-0.16
-4.76%
Martin Midstream Partners LP
ZVSA0.65-0.08
-10.47%
ZyVersa Therapeutics